- Research works
- 4 ▼ 69% vs 2018-21
- Citations
- 115 27.0 per fractional work
- Top-10% rate
- 10.7% all institutions 10.0%
- Open access
- 47% world 40%
- International
- 46% world 18%
Not ranked overall: Middlemore Clinical Trials is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Middlemore Clinical Trials work in?
In all years, 83% of research at Middlemore Clinical Trials is in Health Sciences, 12% in Life Sciences. Its largest fields are Medicine (79%), Biochemistry, Genetics and Molecular Biology (12%), Health Professions (5%). It does 1.6× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 5 fields, with their numbers
- Health Sciences483.3%
- Medicine378.6%
- Health Professions04.8%
- Life Sciences011.9%
- Social Sciences04.8%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Middlemore Clinical Trials publish most on?
By volume in 2022-now: Diabetes Treatment and Management, Medication Adherence and Compliance, Global Public Health Policies and Epidemiology and Diabetes Management and Education.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 2 Medication Adherence and Compliance Family Practice 0 works
- 3 Global Public Health Policies and Epidemiology Organizational Behavior and Human Resource Management 0 works
- 4 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Genetic Syndromes and Imprinting Genetics 0 works
- 7 Hemoglobinopathies and Related Disorders Genetics 0 works
- 8 Platelet Disorders and Treatments Hematology 0 works
- 9 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
- 10 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Middlemore Clinical Trials's research output changed?
Output in 2022-2025 was 69% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Middlemore Clinical Trials as a percentage of every work published that year, 0.0000016% in 2024.
Fractional works of Middlemore Clinical Trials over all fractional works that year. How the balance of science has shifted.
Other research institutions in Auckland
- University of Auckland
- Auckland University of Technology
- Auckland City Hospital
- National Institute of Water and Atmospheric Research
- Unitec Institute of Technology
- Springer Nature (New Zealand)
- North Shore Hospital
- Greenlane Clinical Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Middlemore Clinical Trials. Posts are plain text and can be reported.